Local administration of NF-κ B decoy oligonucleotides to prevent restenosis after balloon angioplasty: An experimental study in New Zealand white rabbits

CardioVascular and Interventional Radiology

Volumn 28, Issue 3, 2005, Pages 331-337

  Kalinowski, Marc ^a   Viehofer, Kerstin ^a   Hamann, Christine ^a   Barry, James J ^b   Kleb, Beate ^a   Klose, Klaus Jochen ^a   Wagner, Hans Joachim ^a   Alfke, Heiko ^a  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

^b BOSTON SCIENTIFIC CORPORATION   (United States)

Author keywords

Angioplasty; Arteries; Catheterization; Catheters; Restenosis

Indexed keywords

DRUG CARRIER; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOSOME; OLIGONUCLEOTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL PROLIFERATION; CHOLESTEROL DIET; CONTROLLED STUDY; DRUG BINDING; DRUG DELIVERY SYSTEM; GENETIC TRANSFECTION; ILIAC ARTERY OBSTRUCTION; IN VITRO STUDY; IN VIVO STUDY; MALE; MORPHOMETRICS; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RABBIT; RANDOMIZATION; RESTENOSIS; STATISTICAL SIGNIFICANCE; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE;

ANGIOPLASTY, BALLOON; ANIMALS; ARTERIAL OCCLUSIVE DISEASES; BALLOON DILATATION; CELL PROLIFERATION; CELLS, CULTURED; CONSTRICTION, PATHOLOGIC; DRUG DELIVERY SYSTEMS; HYPERPLASIA; ILIAC ARTERY; MALE; MUSCLE, SMOOTH, VASCULAR; OLIGODEOXYRIBONUCLEOTIDES; RABBITS; RANDOM ALLOCATION; TUNICA INTIMA;

EID: 21144443577     PISSN: 01741551     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00270-003-0239-y     Document Type: Article

References (35)

1. VM Krepel GJ van Andel WFM van Erp PJ Breslau 1985 Percutaneous transluminal angioplasty of the femoropopliteal artery: Initial and long term results Radiology 156 325 328
2. JA Dormandy RB Rutherford 2000 Management of peripheral arterial disease (PAD). TASC Working Group. Trans-Atlantic Inter-Society Consensus (TASC) J Vasc Surg 31 S1 S296
3. T Jämsen H Manninen H Tulla P Matsi 2002 The final outcome of primary infrainguinal percutaneous transluminal angioplasty in 100 consecutive patients with chronic critical limb ischemia J Vasc Interv Radiol 13 455 463
4. C Bauters T Meurice M Hamon E McFadden JM Lablanche ME Bertrand 1996 Mechanisms and prevention of restenosis: From experimental models to clinical practice Cardiovasc Res 31 835 846
5. MW Liu GS Roubin SBI King 1989 Restenosis after coronary angioplasty: Potential biological determinants and role of intimal hyperplasia Circulation 79 1374 1387
6. JJ Popma RM Califf EJ Topol 1991 Clinical trials of restenosis after coronary angioplasty Circulation 84 1426 1436
7. JH Ip V Fuster L Badimon JJ Badimon MB Taubman JH Chesebro 1991 Syndromes of accelerated atherosclerosis: Role of vascular injury and smooth muscle cell proliferation J Am Coll Cardiol 17 758 769
8. WRM Hermans BJ Rensing BH Strauss PW Serruys 1991 Prevention of restenosis after percutaneous transluminal coronary angioplasty: The search for a "magic bullet" Am Heart J 122 171 187
9. SY Herttuala JF Martin 2000 Cardiovascular gene therapy Lancet 355 213 222
10. HI Manninen K Mäkinen 2002 Gene therapy techniques for peripheral arterial disease Cardiovasc Intervent Radiol 25 98 108
11. U Siebenlist G Francesco K Bown 1994 Structure regulation and function of NF-κ B Annu Rev Cell Biol 10 405 455
12. B Cercek M Yamashita P Dimayuga 1997 Nuclear factor-B activity and arterial response to balloon injury Atherosclerosis 131 59 66
13. JM Breuss M Cejna H Bergmeister A Kadl G Baumgartl S Steurer Z Xu Y Koshelnick J Lipp R De Martin U Losert J Lammer BR Binder 2002 Activation of nuclear factor-B significantly contributes to lumen loss in a rabbit iliac artery balloon angioplasty model Circulation 105 633 638
14. T Bourcier G Sukhova P Libby 1997 The nuclear factor-κ B signaling pathway participates in dysregulation of vascular smooth muscle cells in vitro and in human atherosclerosis J Biol Chem 272 15817 15824
15. K Brand S Page G Rogler 1996 Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion J Clin Invest 97 1715 1722
16. DB Landry LL Couper SR Bryant V Lindner 1997 Activation of the NF-κ B and Iκ B system in smooth muscle cells after rat arterial injury: Induction of vascular cell adhesion molecule-1 and monocyte chemotactic protein-1 Am J Pathol 151 1085 1095
17. KL March BC Trapnell 1997 Pharmacokinetics of local vector delivery to vascular tissues: Implications for efficiency and localization of transduction KL March Gene transfer in the cardiovascular system Kluwer Academic Norwell, MA 477 498
18. R Morishita J Higaki N Tomita T Ogihara 1998 Application of transcription factor decoy strategy as means of gene therapy and study of gene expression in cardiovascular disease Circ Res 82 1023 1028
19. A Bielinska RA Shivdasani LQ Zhang GJ Nabel 1990 Regulation of gene expression with double-stranded phosphorothioate oligonucleotides Science 250 997 1000
20. H Alfke G Stumm I Schnieder KJ Klose J Schlegel 1999 Differential gene expression of vascular smooth muscle cells. Detection by RNA arbitrarily primed polymerase chain reaction Vasa 28 164 168
21. M Kalinowski H Alfke B Kleb F Durfeld H Joachim Wagner 2002 Paclitaxel inhibits proliferation of cell lines responsible for metal stent obstruction: Possible topical application in malignant bile duct obstructions Invest Radiol 37 399 404
22. MK Hong SC Wong A Farb MD Mehlmann R Virmani JJ Barry MB Leon 1993 Feasibility and drug delivery efficiency of a new balloon angioplasty catheter capable of performing simultaneous local drug delivery Coronary Artery Dis 4 1023 1027
23. MV Autieri TL Yue GZ Ferstein E Ohlstein 1995 Antisense oligonucleotide to the p65 subunit of NK-κ B inhibit vascular smooth muscle cell adherence and proliferation and prevent neointima formation in rat carotid arteries Biochem Biophys Res Commun 213 827 836
24. NS Templeton DD Lasic PM Frederik HH Strey DD Roberts GN Pavlakis 1997 Improved DNA:liposome complexes for increased systemic delivery and gene expression Nat Biotechnol 15 647 652
25. M Cejna JM Breuss H Bergmeister 2002 Inhibition of neointimal formation after stent placement with adenovirus-mediated gene transfer of I-κ B in the hypercholesterolemic rabbit model: Initial results Radiology 223 702 708
26. S Plante G Dupuis CJ Mongeau P Durand 1994 Porous balloon catheters for local delivery: Assessment of vascular damage in a rabbit iliac angioplasty model J Am Coll Cardiol 24 820 824
27. C Herdeg M Oberhoff A Baumbach KK Haase B Horch A Kranzhoefer KR Karsch 1997 Local drug delivery with porous balloons in the rabbit: Assessment of vascular injury for an improvement of application parameters Cathet Cardiovasc Diagn 41 308 314
28. B Goldman H Blanke H Wolinsky 1987 Influence of pressure on permeability of normal and diseased muscular arteries to horseradish peroxidase A new catheter approach. Atherosclerosis 65 215 225
29. J Pelisek MG Engelmann A Golda A Fuchs S Armeanu M Shimizu C Mekkaoui PH Rolland S Nikol 2002 Optimization of nonviral transfection: Variables influencing liposome-mediated gene transfer in proliferating vs. quiescent cells in culture and in vivo using a porcine restenosis model J Mol Med 80 724 736
30. DD Lasic NS Templeton 2000 Bioorganic colloids: Macromolecules, DNA, self-assembled particles, and their complexes NS Templeton DD Lasic Gene therapy Marcel Dekker New York
31. T Scott-Burden DA Engler CL Tock JJ Schwarz SW Casscells 1997 Liposomal induction of NO synthase expression in cultured vascular smooth muscle cells Biochem Biophys Res Commun 24 780 783
32. DWM Muller SG Ellis EJ Topol 1992 Experimental models of coronary artery restenosis J Am Coll Cardiol 19 418 432
33. M Kalinowski H Alfke S Bergen KJ Klose JJ Barry HJ Wagner 2001 Comparative trial of local pharmacotherapy with L-arginine, r-hirudin and molsidomine to reduce restenosis after balloon angioplasty of stenotic rabbit iliac arteries Radiology 219 716 723
34. PS Teirstein RE Kuntz 2001 New frontiers in interventional cardiology: Intravascular radiation to prevent restenosis Circulation 104 2620 2626
35. JE Sousa MA Costa AC Abizaid BJ Rensing AS Abizaid LF Tanajura 2001 Sustained suppression of neointimal proliferation by sirolimus-eluting stents: One-year angiographic and intravascular ultrasound follow-up Circulation 104 2007 2011